Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
NOVA1 encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. Zusätzlich bieten wir Ihnen NOVA1 Proteine (10) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 76 products:
Human Polyclonal NOVA1 Primary Antibody für IHC (p), IHC - ABIN314323
Jelen, Ule, Zivin, Darnell: Evolution of Nova-dependent splicing regulation in the brain. in PLoS genetics 2007
Human Polyclonal NOVA1 Primary Antibody für ELISA, WB - ABIN562029
Jelen, Ule, Zivin: Cholinergic regulation of striatal Nova mRNAs. in Neuroscience 2010
Human Polyclonal NOVA1 Primary Antibody für ICC, IF - ABIN4340455
Li, Sun, Wang, Gao, Liu, Gao, Li, Zhang: Dynamic expression pattern of neuro-oncological ventral antigen 1 (Nova1) in the rat brain after focal cerebral ischemia/reperfusion insults. in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2012
overexpression of miR (zeige MLXIP Antikörper)-203a-3p leads to a decrease of NOVA1, counter-balanced by an increase of IKAP (zeige IKBKAP Antikörper), supporting a potential interaction between NOVA1 and IKAP (zeige IKBKAP Antikörper).
NOVA1 suppression was frequently noted in the gastric cancer microenvironment, and attenuated NOVA1 expression in tumor cells was associated with tumor progression and poor prognosis.
Nova1 interacts with GABAARgamma2 not only in the central nervous system but also in hepatocellular carcinoma. Nova1's potential mechanism as an oncogene (zeige RAB1A Antikörper) may due to its interaction with GABAA (zeige GABRg1 Antikörper) Rgamma2.
Loss of NOVA1 is associated with gastric cancer.
Quantitative proteomic analysis was performed to help elucidate a molecular distinction between glioblastoma and oligodendroglioma; analysis showed HSPB1 (zeige HSPB1 Antikörper) and NOVA1 to be discriminating factors.
Data indicate RNA binding protein (zeige PTBP1 Antikörper) NOVA1 as a target of microRNA miR (zeige MLXIP Antikörper)-339.
MiR (zeige MLXIP Antikörper)-181b-5p is a tumor suppressor in astrocytoma that inhibits tumor progression by targeting NOVA1.
High expression of NOVA1 correlates with poor prognosis in hepatocellular carcinoma.
a regulation of LEDGF (zeige PSIP1 Antikörper) interaction with chromatin by cellular partners of its PWWP domain could be involved in several processes linked to LEDGF (zeige PSIP1 Antikörper) tethering properties, such as lentiviral integration, DNA repair or transcriptional regulation
Gene silencing and overexpression of the nELAV member HuD (zeige ELAVL4 Antikörper) in motoneuronal NSC34 cells indicate that Nova1 mRNA stability and translation are positively and strongly controlled by the nELAV proteins
Together, these results demonstrate that the production of DCC (zeige DCC Antikörper) splice variants controlled by NOVA (zeige HNRNPK Antikörper) has a crucial function during many stages of commissural neuron development.
Phenotypic analysis of the NOVA (zeige HNRNPK Antikörper)-deficient mice demonstrated increased adipose tissue thermogenesis and improved glycemia.
RBM4a (zeige RBM4 Antikörper) ablation enhanced the relative level of exon 4-excluded neuro-oncological ventral antigen 1 (Nova1(-4)) transcripts, which were predominantly generated in embryonic BAs
identify Nova-1 and hnRNP M (zeige HNRNPM Antikörper) as D2R (zeige DRD2 Antikörper) pre-mRNA-binding proteins and show their antagonistic role in the alternative splicing of D2R (zeige DRD2 Antikörper) pre-mRNA.
integrative network revealed combinatorial regulation by Nova (zeige HNRNPK Antikörper) and the neuronal splicing factor (zeige SLU7 Antikörper) Fox, interplay between phosphorylation and splicing, and potential links to neurologic disease
Nova (zeige HNRNPK Antikörper) regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer
CLIP (cross-linking and immunoprecipitation) reveals Nova (zeige HNRNPK Antikörper) coordinately regulates a biologically coherent set of RNAs encoding multiple components of the inhibitory synapse, an observation that may relate to the cause of abnormal motor inhibition in POMA
These studies demonstrate that in addition to its previously described role as a splicing activator, Nova-1 autoregulates its own expression by acting as a splicing repressor.
Assays of splicing intermediates of Nova (zeige HNRNPK Antikörper)-regulated transcripts in mouse brain revealed that Nova (zeige HNRNPK Antikörper) preferentially regulates removal of introns harbouring (or closest to) YCAY clusters
This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described.
neuro-oncological ventral antigen 1
, lipid A export ATP-binding/permease protein
, RNA-binding protein Nova-1
, onconeural ventral antigen 1
, paraneoplastic Ri antigen
, ventral neuron-specific protein 1